Clovis Oncology reported $646.88M in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Agenus AGEN:US $ 13.7M 0.48M
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Arrowhead Research ARWR:US $ 0M 0M
Astrazeneca AZN:US $ 29528M 1571M
AstraZeneca AZN:LN 29528M 1571M
Cerulean Pharma CERU:US $ 0M 0M
Clovis Oncology CLVS:US $ 646.88M 15.88M
Eli Lilly And LLY:US $ 16813.8M 305M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Esperion Therapeutics ESPR:US $ 259.08M 402K
GlaxoSmithKline GSK:LN 22111M 11217M
Halozyme Therapeutics HALO:US $ 1246.18M 368.53M
Heron Therapeutics HRTX:US $ 149.18M 0.05M
Insmed INSM:US $ 807.32M 534K
Intrexon XON:US $ 198.67M 2.79M
Ligand Pharmaceuticals LGND:US $ 115.02M 61.57M
Mirati Therapeutics MRTX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 31031M 244M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Rigel Pharmaceuticals RIGL:US $ 29.84M 0.01M
Sangamo Biosciences SGMO:US $ 0M 0M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Veracyte VCYT:US $ 1.73M 0.05M
YTE INCY:US $ 34.19M 0.01M